PLK1 and hepatocellular carcinoma: In HCC PLK1 expression, which is associated with cell cycle, is often elevated and a phase 2 trial using an LNP siRNA model is currently in progress to determine its use as an HCC drug to modulate proliferation/apoptosis (79).